Johnson & Johnson a fait état d’une augmentation de 6,5% des ventes de son traitement Stelara (ustekinumab) pour les patients pédiatriques atteints de rhumatisme psoriasique
Johnson & Johnson posted a 6.5% year-over-year increase in sales of its Stelara (ustekinumab) treatment for pediatric patients with juvenile psoriatic arthritis in 2022, to
The market for equipment and sleep treatments continues to trend upward both in the United States and worldwide, according to Remsleep Holdings. An increasingly sedentary
Tagrisso ranked # 1 among AstraZeneca’s top medicines by the amount of its sales in 2020. Sales of this drug totaled $ 4.328 million last
People with diabetes are twice as likely to have a serious illness or die, and 28% of cancer patients who got Covid-19 died, compared to
Johnson & Johnson a fait état d’une augmentation de 6,5% des ventes de son traitement Stelara (ustekinumab) pour les patients pédiatriques atteints de rhumatisme psoriasique
Johnson & Johnson posted a 6.5% year-over-year increase in sales of its Stelara (ustekinumab) treatment for pediatric patients with juvenile psoriatic arthritis in 2022, to
The market for equipment and sleep treatments continues to trend upward both in the United States and worldwide, according to Remsleep Holdings. An increasingly sedentary
Tagrisso ranked # 1 among AstraZeneca’s top medicines by the amount of its sales in 2020. Sales of this drug totaled $ 4.328 million last
People with diabetes are twice as likely to have a serious illness or die, and 28% of cancer patients who got Covid-19 died, compared to
Redacción: 7224059128
info@opportimes.com
